Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy
Science Advances · 12.09.2025 · 11 (37)
DOI: 10.1126/sciadv.adx6489 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Advances, erschienen am 12.09.2025. Verfasst von Gujie Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Immunotherapy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The interplay between cellular metabolism and immune regulation is central to immune function and disease progression, revealing notable therapeutic opportunities. Upon activation, immune cells undergo metabolic reprogramming to meet heightened demands for energy and biosynthesis, reshaping regulatory networks across epigenomic, transcriptomic, and proteomic layers. Metabolite-derived posttranslational modifications (PTMs) serve as pivotal mechanisms integrating metabolic intermediates with immune signaling pathways. Beyond classical acetylation, diverse nonacetyl PTMs—including lactylation, succinylation, malonylation, palmitoylation, and myristoylation—modify histone and nonhistone proteins, regulating gene expression, protein stability, subcellular localization, enzymatic activity, and protein-protein interactions. Advances in mass spectrometry and bioinformatics now enable precise characterization of these PTMs, uncovering their broad roles in immune regulation. This review summarizes current progress in immunometabolism and explores future directions such as mechanistic studies, combination strategies, and clinical applications. Metabolite-driven PTMs critically connect metabolism to immune regulation, suggesting promising therapeutic approaches for cancer, autoimmune disorders, and inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Shandong Medical College, Jinan 250002, Shandong, China.
- Regenerative Medicine Institute, School of Medicine, National University of Ireland, H91 TK33 Galway, Ireland.
- Einstein Pathology Single-cell & Bioinformatics Laboratory, Bronx, NY 10461, USA.
- Laboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
ORCID-Profile: Gujie Wu, Lin Cheng, Yiwei Huang, Shanye Yin
Zitieren
APA
Wu, G., Fan, X., Cheng, L., Chen, Z., Yi, Y., Liang, J., Huang, X., Yang, N., Yin, J., Guo, W., Huang, Y., & Yin, S. (2025). Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy. Science Advances, 11(37). https://doi.org/10.1126/sciadv.adx6489
Vancouver
Wu G, Fan X, Cheng L, Chen Z, Yi Y, Liang J, et al. Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy. Science Advances. 2025;11(37). doi:10.1126/sciadv.adx6489
BibTeX
@article{Wu2025,
author = {Wu, Gujie and Fan, Xiaofei and Cheng, Lin and Chen, Zongwei and Yi, Yanjun and Liang, Jiaqi and Huang, Xiaolong and Yang, Na and Yin, Jiacheng and Guo, Weigang and Huang, Yiwei and Yin, Shanye},
title = {Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {37},
doi = {10.1126/sciadv.adx6489}
}
EUVIMED